Home › Narcolepsy › South Carolina
Pag-aaral pangklinika para sa Narcolepsy sa South Carolina
7 pag-aaral para sa Narcolepsy ang naghahanap ng mga kalahok sa mga site sa South Carolina.
Mga Lungsod sa South Carolina
Opisyal na teksto ng pag-aaral (English)
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
- Lowcountry Lung and Critical Care PA, Charleston
- Medical University of South Carolina, Charleston
- Bogan Sleep Consultants, LLC, Columbia
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07675135A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
- Columbia, South Carolina, Columbia
Nagre-recruitPhase 2/3
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07598708A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
- Alkermes Investigational Site, Columbia
Nagre-recruitPhase 2/3
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Okt 9, 2026 · NCT06767683A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
- Alkermes Investigational Site, Columbia
Nagre-recruitPhase 3
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Okt 7, 2026 · NCT07455383A Phase 3 Study to Evaluate the Efficacy and Safety of Samelisant in Patients With Narcolepsy (AWAKE)
- Bogan Sleep Consultants, Columbia
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07540364A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy
- Bogan Sleep Consultants, LLC, Columbia
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update May 14, 2026 · NCT07493265A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
- North Charleston, South Carolina, North Charleston
Nagre-recruitPhase 2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Abr 16, 2026 · NCT07096674Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.